Lv4
590 积分 2023-06-07 加入
Achievement of target LDL-cholesterol level in patients with acute coronary syndrome undergoing percutaneous coronary intervention: The JET-LDL registry
2个月前
已完结
Comparative effects of high-dose atorvastatin versus rosuvastatin on lipid parameters, oxidized low-density lipoprotein, and proprotein convertase subtilisin kexin 9 in acute coronary syndrome
2个月前
已完结
Early effect of PCSK 9 inhibitor: Evolocumab vs alirocumab
2个月前
已完结
Early Initiation of Evolocumab Treatment in Chinese Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
2个月前
已完结
Early use of PCSK9 inhibitors in the prognosis of patients with acute coronary syndrome by protecting vascular endothelial function
2个月前
已关闭
Effect of Evolocumab on Changes in Coronary Plaque Phenotype in Statin-Treated Patients Following Myocardial Infarction: The HUYGENS Randomised Clinical Trial
2个月前
已完结
Efficacy and Safety of Evolocumab in Reducing Low-Density Lipoprotein Cholesterol Levels in Chinese Patients with Non-ST-segment Elevation Acute Coronary Syndrome
2个月前
已完结
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
2个月前
已完结
First clinical experiences with inclisiran in a real-world setting
2个月前
已完结
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Emergency Complex Higher-risk and Indicated Patients
2个月前
已完结
皖公网安备34019202002308
